Terms: = Sarcomas AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Prognosis
26 results:
1. Next-generation sequencing in breast pathology: real impact on routine practice over a decade since its introduction.
Nourieh M; Vibert R; Saint-Ghislain M; Cyrta J; Vincent-Salomon A
Histopathology; 2023 Jan; 82(1):162-169. PubMed ID: 36482269
[TBL] [Abstract] [Full Text] [Related]
2. Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma?
Rémond MS; Pellat A; Brezault C; Dhooge M; Coriat R
ESMO Open; 2022 Dec; 7(6):100638. PubMed ID: 36399952
[TBL] [Abstract] [Full Text] [Related]
3. S1 Guidelines for the Kaposi Sarcoma.
Esser S; Schöfer H; Hoffmann C; Claßen J; Kreuter A; Leiter U; Oette M; Becker JC; Ziemer M; Mosthaf F; Sirokay J; Ugurel S; Potthoff A; Helbig D; Bierhoff E; Schulz TF; Brockmeyer NH; Grabbe S
J Dtsch Dermatol Ges; 2022 Jun; 20(6):892-904. PubMed ID: 35657085
[TBL] [Abstract] [Full Text] [Related]
4. Hidden in the Eyes-Recurrence of Systemic Hemopathies Reportedly "In Remission": Six Cases and Review of Literature.
Denier M; Tick S; Dubois R; Dulery R; Eller AW; Suarez F; Burroni B; Maurage CA; Bories C; Konopacki J; Puech M; Bouscary D; Cantalloube A; Héron E; Marçais A; Habas C; Theillac V; Keilani C; Bonhomme GR; Gallagher DS; Boumendil J; Abarah W; Sedira N; Bertin S; Choquet S; Sahel JA; Merabet L; Brignole-Baudouin F; Putterman M; Errera MH
Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334633
[No Abstract] [Full Text] [Related]
5. Development and external validation of nomograms to predict sarcoma-specific death and disease progression after surgical resection of localized high-grade conventional primary central chondrosarcoma and dedifferentiated chondrosarcoma.
Tsuda Y; Tsoi K; Stevenson JD; Laitinen M; Ferguson PC; Wunder JS; Griffin AM; van de Sande MAJ; van Praag V; Leithner A; Fujiwara T; Yasunaga H; Matsui H; Parry MC; Jeys LM
Bone Joint J; 2020 Dec; 102-B(12):1752-1759. PubMed ID: 33249892
[TBL] [Abstract] [Full Text] [Related]
6. Molecular signatures of BRCAness analysis identifies PARP inhibitor Niraparib as a novel targeted therapeutic strategy for soft tissue sarcomas.
Li H; Tu J; Zhao Z; Chen L; Qu Y; Li H; Yao H; Wang X; Lee DF; Shen J; Wen L; Huang G; Xie X
Theranostics; 2020; 10(21):9477-9494. PubMed ID: 32863940
[No Abstract] [Full Text] [Related]
7. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
[TBL] [Abstract] [Full Text] [Related]
8. Chylous ascites in disseminated Kaposi sarcoma: an unusual manifestation as immune reconstitution inflammatory syndrome.
Cipriano P; Nabais I; Melo N; Alves AR
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30904896
[TBL] [Abstract] [Full Text] [Related]
9. The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma.
Park HJ; Bae JS; Kim KM; Moon YJ; Park SH; Ha SH; Hussein UK; Zhang Z; Park HS; Park BH; Moon WS; Kim JR; Jang KY
J Exp Clin Cancer Res; 2018 May; 37(1):107. PubMed ID: 29784019
[TBL] [Abstract] [Full Text] [Related]
10. Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma.
Volkow P; Cesarman-Maus G; Garciadiego-Fossas P; Rojas-Marin E; Cornejo-Juárez P
AIDS Res Ther; 2017 May; 14(1):30. PubMed ID: 28558783
[TBL] [Abstract] [Full Text] [Related]
11. [Sensitivity of doxorubicin-resistant osteosarcoma cells to doxorubicin regulated by long non-coding RNA NR_036444].
Zhu KP; Zhang CL
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):250-255. PubMed ID: 28550663
[No Abstract] [Full Text] [Related]
12. Molecular classification of pulmonary sarcomatoid carcinomas suggests new therapeutic opportunities.
Pécuchet N; Vieira T; Rabbe N; Antoine M; Blons H; Cadranel J; Laurent-Puig P; Wislez M
Ann Oncol; 2017 Jul; 28(7):1597-1604. PubMed ID: 28419182
[TBL] [Abstract] [Full Text] [Related]
13. Clinical Significance of DNA Damage Response Factors and Chromosomal Instability in Primary Lung Adenocarcinoma.
Okamoto T; Kohno M; Ito K; Takada K; Katsura M; Morodomi Y; Toyokawa G; Shoji F; Maehara Y
Anticancer Res; 2017 Apr; 37(4):1729-1735. PubMed ID: 28373435
[TBL] [Abstract] [Full Text] [Related]
14. Individual and Combined Expression of DNA Damage Response Molecules PARP1, γH2AX, brca1, and BRCA2 Predict Shorter Survival of Soft Tissue Sarcoma Patients.
Kim KM; Moon YJ; Park SH; Park HJ; Wang SI; Park HS; Lee H; Kwon KS; Moon WS; Lee DG; Kim JR; Jang KY
PLoS One; 2016; 11(9):e0163193. PubMed ID: 27643881
[TBL] [Abstract] [Full Text] [Related]
15. The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets.
Chong DQ; Zhu AX
Oncotarget; 2016 Jul; 7(29):46750-46767. PubMed ID: 27102149
[TBL] [Abstract] [Full Text] [Related]
16. Trabectedin is a promising antitumour agent for synovial sarcoma.
Yasui H; Imura Y; Outani H; Hamada K; Nakai T; Yamada S; Takenaka S; Sasagawa S; Araki N; Itoh K; Myoui A; Yoshikawa H; Naka N
J Chemother; 2016 Oct; 28(5):417-24. PubMed ID: 27077926
[TBL] [Abstract] [Full Text] [Related]
17. Combinations of PARP Inhibitors with Temozolomide Drive PARP1 Trapping and Apoptosis in Ewing's Sarcoma.
Gill SJ; Travers J; Pshenichnaya I; Kogera FA; Barthorpe S; Mironenko T; Richardson L; Benes CH; Stratton MR; McDermott U; Jackson SP; Garnett MJ
PLoS One; 2015; 10(10):e0140988. PubMed ID: 26505995
[TBL] [Abstract] [Full Text] [Related]
18. Clinical case of the month: a 22-year-old man with AIDS presenting with shortness of breath and an oral lesion.
Englert D; Seal P; Parsons C; Arbour A; Roberts E; Lopez FA
J La State Med Soc; 2014; 166(5):224-30. PubMed ID: 25369228
[TBL] [Abstract] [Full Text] [Related]
19. [Primary ovarian malignant mixed mesodermal tumor (MMMT) as a second primary tumor in a patient with invasive breast carcinoma--case report].
Sentija K; Bolanca IK; Simon SK; Kukura V; Skrtić A; Gasparov S
Acta Med Croatica; 2011 Sep; 65 Suppl 1():229-34. PubMed ID: 23126058
[TBL] [Abstract] [Full Text] [Related]
20. [Hemangiosarcoma after breast-conserving therapy of breast cancer: report of four cases with molecular genetic diagnosis and literature review].
Nestle-Krämling C; Bölke E; Budach W; Peiper M; Niederacher D; Janni W; Eisenberger CF; Knoefel WT; Scherer A; Baldus SE; Lammering G; Gerber PA; Matuschek C
Strahlenther Onkol; 2011 Oct; 187(10):656-64. PubMed ID: 21858416
[TBL] [Abstract] [Full Text] [Related]
[Next]
